| 1 |
34740892 | Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance. | 2022 Jan 1 |
3 |
| 2 |
35052449 | Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders. | 2022 Jan 5 |
1 |
| 3 |
35098567 | Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptides. | 2022 May |
1 |
| 4 |
33219721 | The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling. | 2021 Feb |
1 |
| 5 |
33335793 | A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa Cells. | 2021 Mar 5 |
2 |
| 6 |
31940495 | Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor. | 2020 Jan 14 |
2 |
| 7 |
32934110 | Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA). | 2020 Oct |
1 |
| 8 |
30135193 | Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer. | 2018 Oct 15 |
3 |
| 9 |
28129131 | 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells. | 2017 Jan 4 |
3 |
| 10 |
25634993 | Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth. | 2015 Apr 1 |
1 |
| 11 |
24890318 | Targeting the androgen receptor in prostate cancer. | 2014 Jul |
1 |
| 12 |
23554843 | Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression. | 2013 Apr |
1 |
| 13 |
24169353 | First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. | 2013 Nov 12 |
4 |
| 14 |
21869905 | In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides. | 2011 Apr |
1 |
| 15 |
22164193 | In LNCaP cells enhanced expression of both androgen receptor and costimulatory protein p300 compensate for antisense oligonucleotide suppression of bcl-2. | 2011 Dec |
1 |
| 16 |
19059367 | DNA dependent recruitment of DDX17 and other interacting proteins by the human androgen receptor. | 2009 Feb |
3 |
| 17 |
19186031 | Silencing the androgen receptor: new skills for antiandrogen oligonucleotide skin and hair therapy. | 2009 May |
1 |
| 18 |
18270197 | Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro. | 2008 Apr 18 |
1 |
| 19 |
19080333 | Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. | 2008 Nov 20 |
3 |
| 20 |
19080439 | [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice]. | 2008 Jul 29 |
3 |
| 21 |
17326011 | Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. | 2007 Feb |
5 |
| 22 |
17326012 | Responsiveness to androgens and effectiveness of antisense oligonucleotides against the androgen receptor on human epidermal keratinocytes is dependent on the age of the donor and the location of cell origin. | 2007 Feb |
3 |
| 23 |
17433535 | 14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens. | 2007 Aug 28 |
1 |
| 24 |
17679089 | A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. | 2007 Aug 3 |
1 |
| 25 |
17728259 | Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. | 2007 Nov 2 |
1 |
| 26 |
16598769 | Androgen axis in prostate cancer. | 2006 Oct 1 |
1 |
| 27 |
16166329 | Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. | 2005 Sep 15 |
1 |
| 28 |
15176163 | Antiandrogen oligonucleotides: active principles in hair- and skin-derived culture cells. | 2004 May-Jun |
3 |
| 29 |
12539229 | R726L androgen receptor mutation is uncommon in prostate cancer families in the united states. | 2003 Mar 1 |
1 |
| 30 |
12664061 | Specific block of androgen receptor activity by antisense oligonucleotides. | 2003 |
2 |
| 31 |
12799773 | A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. | 2003 Jun |
1 |
| 32 |
12891627 | Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells. | 2003 Aug |
3 |
| 33 |
11857028 | Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor. | 2002 Feb |
1 |
| 34 |
12237244 | Androgen receptors in prostate cancer. | 2002 Sep |
1 |
| 35 |
11606392 | Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. | 2001 Oct 15 |
2 |
| 36 |
12083956 | Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy. | 2001 |
1 |
| 37 |
10917202 | Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. | 2000 Jul |
1 |
| 38 |
11162897 | Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. | 2000 Dec 22 |
2 |
| 39 |
10075669 | Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. | 1999 Mar 19 |
2 |
| 40 |
10477908 | "Decoy" of androgen-responsive element induces apoptosis in LNCaP cells. | 1999 Oct 1 |
1 |
| 41 |
9212051 | Identification of a functional androgen-response element in the exon 1-coding sequence of the cystatin-related protein gene crp2. | 1997 Jul |
1 |
| 42 |
9233568 | Further evidence for the importance of an androgen response element in the factor IX promoter. | 1997 Jul |
3 |
| 43 |
9001799 | Rapid detection of a mutation hot-spot in the human androgen receptor. | 1996 Oct |
1 |
| 44 |
7748811 | Androgens induce divergent proliferative responses in human breast cancer cell lines. | 1995 May |
2 |
| 45 |
7514587 | Human androgen receptor binding to the androgen response element of prostate specific antigen. | 1994 Jan-Feb |
1 |
| 46 |
7968281 | Detection of human androgen receptor mRNA in hepatocellular carcinoma by in situ hybridisation. | 1994 Aug |
1 |
| 47 |
8312279 | Regulatory mechanism of human factor IX gene: protein binding at the Leyden-specific region. | 1994 Feb 15 |
2 |
| 48 |
1424203 | Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome. | 1992 Sep |
1 |
| 49 |
1491700 | A consensus DNA-binding site for the androgen receptor. | 1992 Dec |
1 |
| 50 |
2293020 | Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. | 1990 Aug |
1 |